Best Practices Forum: The role of icosapent ethyl for CV risk reduction
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
Perspectives from family practice, diabetology, and cardiology
Overview & Objectives
Perspectives from primary care,diabetology and cardiology.
|Are serum triglycerides a risk factor?|
|Do fish oils reduce CV risk?|
|How does icosapent ethyl differ from fish oils?|
|What are the main results of the REDUCE-IT study?|
|What is the mechanism of benefit?|
|How should we use icosapent ethyl in our practices?|
This program was developed by the Canadian Collaborative Research Network and made possible through an educational grant from HLS Therapeutics Canada.
Links & Resources
Download program slides - PDF